SEARCH

SEARCH BY CITATION

REFERENCES

  • 1
    Krause ML, Cartin-Ceba R, Specks U, Peikert T.Update on diffuse alveolar hemorrhage and pulmonary vasculitis. Immunol Allergy Clin North Am2012;32:587600.
  • 2
    Lara AR, Schwarz MI.Diffuse alveolar hemorrhage. Chest2010;137:116471.
  • 3
    Lee AS, Specks U.Pulmonary capillaritis. Semin Respir Crit Care Med2004;25:54755.
  • 4
    Specks U.Diffuse alveolar hemorrhage syndromes. Curr Opin Rheumatol2001;13:127.
  • 5
    Al-Hajjaj MS.Massive pulmonary hemorrhage in a Saudi female with primary antiphospholipid syndrome. Saudi Med J2000;21:7779.
  • 6
    Crausman RS, Achenbach GA, Pluss WT, O'Brien RF, Jennings CA.Pulmonary capillaritis and alveolar hemorrhage associated with the antiphospholipid antibody syndrome. J Rheumatol1995;22:5546.
  • 7
    Deane KD, West SG.Antiphospholipid antibodies as a cause of pulmonary capillaritis and diffuse alveolar hemorrhage: a case series and literature review. Semin Arthritis Rheum2005;35:15465.
  • 8
    Gertner E.Diffuse alveolar hemorrhage in the antiphospholipid syndrome: spectrum of disease and treatment. J Rheumatol1999;26:8057.
  • 9
    Gertner E, Lie JT.Pulmonary capillaritis, alveolar hemorrhage, and recurrent microvascular thrombosis in primary antiphospholipid syndrome. J Rheumatol1993;20:12248.
  • 10
    Hillerdal G, Hagg A, Licke G, Wegenius G, Scheibenpflug L.Intra-alveolar haemorrhage in the anticardiolipin antibody syndrome. Scand J Rheumatol1991;20:5862.
  • 11
    Lafosse-Marin M, Marcq M, Diot P, Gruel Y, Diot E.Intra-alveolar pulmonary haemorrhage, an unusual manifestation of the primary antiphospholipid syndrome. Rev Med Interne2009;30:2713. In French.
  • 12
    Marcos Rodriguez PJ, Montero Martinez C, Verea Hernando H.Pulmonary haemorrhage and primary antiphospholipid syndrome: case report and review. An Med Interna2007;24:1258. In Spanish.
  • 13
    Martinez-Vazquez C, Perez S, Bordon J, Ordi-Ros J, Ribera A, Lopez A.Pulmonary hemorrhage and anti-phospholipid syndrome. Rev Clin Esp2004;204:52831. In Spanish.
  • 14
    Scheiman Elazary A, Klahr PP, Hershko AY, Dranitzki Z, Rubinow A, Naparstek Y.Rituximab induces resolution of recurrent diffuse alveolar hemorrhage in a patient with primary antiphospholipid antibody syndrome. Lupus2012;21:43840.
  • 15
    Suzuki A, Asazuma N, Kikuchi E, Kawanobe T, Horimoto Y, Yokobari R, et al.“Possible primary antiphospholipid syndrome” with concurrent diffuse alveolar hemorrhaging and Libman-Sacks endocarditis mimicking catastrophic antiphospholipid syndrome. Intern Med2012;51:8136.
  • 16
    Waterer GW, Latham B, Waring JA, Gabbay E.Pulmonary capillaritis associated with the antiphospholipid antibody syndrome and rapid response to plasmapheresis. Respirology1999;4:4058.
  • 17
    Wilson WA, Gharavi AE, Koike T, Lockshin MD, Branch DW, Piette JC, et al.International consensus statement on preliminary classification criteria for definite antiphospholipid syndrome: report of an international workshop. Arthritis Rheum1999;42:130911.
  • 18
    Miyakis S, Lockshin MD, Atsumi T, Branch DW, Brey RL, Cervera R, et al.International consensus statement on an update of the classification criteria for definite antiphospholipid syndrome (APS). J Thromb Haemost2006;4:295306.
  • 19
    Jeffrey PJ, Asherson RA, Rees PJ.Recurrent deep vein thrombosis, thromboembolic pulmonary hypertension and the ‘primary’ antiphospholipid syndrome. Clin Exp Rheumatol1989;7:5679.
  • 20
    Anderson NE, Ali MR.The lupus anticoagulant, pulmonary thromboembolism, and fatal pulmonary hypertension. Ann Rheum Dis1984;43:7603.
  • 21
    Luchi ME, Asherson RA, Lahita RG.Primary idiopathic pulmonary hypertension complicated by pulmonary arterial thrombosis: association with antiphospholipid antibodies. Arthritis Rheum1992;35:7005.
  • 22
    Asherson RA, Cervera R.Catastrophic antiphospholipid syndrome. Curr Opin Hematol2000;7:3259.
  • 23
    Asherson RA, Cervera R, de Groot PG, Erkan D, Boffa MC, Piette JC, et al.Catastrophic antiphospholipid syndrome: international consensus statement on classification criteria and treatment guidelines. Lupus2003;12:5304.
  • 24
    Espinosa G, Cervera R, Font J, Asherson RA.The lung in the antiphospholipid syndrome. Ann Rheum Dis2002;61:1958.
  • 25
    Ford HJ, Roubey RA.Pulmonary manifestations of the antiphospholipid antibody syndrome. Clin Chest Med2010;31:53745.
  • 26
    Asherson RA, Greenblatt MA.Recurrent alveolar hemorrhage and pulmonary capillaritis in the “primary” antiphospholipid syndrome. J Clin Rheumatol2001;7:303.
  • 27
    Girardi G, Berman J, Redecha P, Spruce L, Thurman JM, Kraus D, et al.Complement C5a receptors and neutrophils mediate fetal injury in the antiphospholipid syndrome. J Clin Invest2003;112:164454.
  • 28
    Bucciarelli S, Espinosa G, Asherson RA, Cervera R, Claver G, Gomez-Puerta JA, et al.The acute respiratory distress syndrome in catastrophic antiphospholipid syndrome: analysis of a series of 47 patients. Ann Rheum Dis2006;65:816.
  • 29
    Cuchacovich R, Espinoza LR.Is antiphospholipid antibody determination clinically relevant to the vasculitides? Semin Arthritis Rheum2001;31:13.
  • 30
    Aron AL, Gharavi AE, Shoenfeld Y.Mechanisms of action of antiphospholipid antibodies in the antiphospholipid syndrome. Int Arch Allergy Immunol1995;106:812.
  • 31
    Garcia CO, Kanbour-Shakir A, Tang H, Molina JF, Espinoza LR, Gharavi AE.Induction of experimental antiphospholipid antibody syndrome in PL/J mice following immunization with β 2 GPI. Am J Reprod Immunol1997;37:11824.
  • 32
    George J, Blank M, Levy Y, Meroni P, Damianovich M, Tincani A, et al.Differential effects of anti-β2-glycoprotein I antibodies on endothelial cells and on the manifestations of experimental antiphospholipid syndrome. Circulation1998;97:9006.
  • 33
    Del Papa N, Guidali L, Sala A, Buccellati C, Khamashta MA, Ichikawa K, et al.Endothelial cells as target for antiphospholipid antibodies: human polyclonal and monoclonal anti–β2-glycoprotein I antibodies react in vitro with endothelial cells through adherent β2-glycoprotein I and induce endothelial activation. Arthritis Rheum1997;40:55161.
  • 34
    Lie JT.Vasculitis in the antiphospholipid syndrome: culprit or consort? J Rheumatol1994;21:3979.
  • 35
    Chakravarty K, Pountain G, Merry P, Byron M, Hazleman B, Scott DG.A longitudinal study of anticardiolipin antibody in polymyalgia rheumatica and giant cell arteritis. J Rheumatol1995;22:16947.
  • 36
    Duhaut P, Berruyer M, Pinede L, Demolombe-Rague S, Loire R, Seydoux D, et al, for the Groupe de Recherche sur l'Arterite a Cellules Geantes.Anticardiolipin antibodies and giant cell arteritis: a prospective, multicenter case–control study. Arthritis Rheum1998;41:7019.
  • 37
    Espinoza LR, Jara LJ, Silveira LH, Martinez-Osuna P, Zwolinska JB, Kneer C, et al.Anticardiolipin antibodies in polymyalgia rheumatica-giant cell arteritis: association with severe vascular complications. Am J Med1991;90:4748.
  • 38
    Seriolo B, Accardo S, Cutolo M.Lipoprotein(a) and anticardiolipin antibodies as risk factors for thrombotic events in polymyalgia rheumatica and giant cell arteritis. J Rheumatol1996;23:147880.
  • 39
    Hashimoto N, Iwasaki T, Sekiguchi M, Takatsuka H, Okamoto T, Hashimoto T, et al.Autologous hematopoietic stem cell transplantation for refractory antiphospholipid syndrome causing myocardial necrosis. Bone Marrow Transplant2004;33:8636.
  • 40
    Statkute L, Traynor A, Oyama Y, Yaung K, Verda L, Krosnjar N, et al.Antiphospholipid syndrome in patients with systemic lupus erythematosus treated by autologous hematopoietic stem cell transplantation. Blood2005;106:27009.
  • 41
    Owaidah TM, Maghrabi K, Elkarouri MA, Al Mohareeb F, Al Harthi A, Al Zahrani H.Successful treatment of a case of catastrophic antiphospholipid syndrome with autologous BMT: case report and review of literature. Bone Marrow Transplant2011;46:597600.